Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

11:15 EST 25th November 2015 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 840

Extremely Relevant

Propagermanium and irbesartan: Phase II started


Pulmonary Hypertension Association (PHA) Names ‘Periwinkle Pioneers’: Honor Recognizes 25 Years of Pulmonary Hypertension (PH) Advancements

Silver Spring, Md (PRWEB) November 25, 2015 In honor of Pulmonary Hypertension Awareness Month, the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pi...

Researchers boost hypertension treatment using unconventional approach

Using approved drugs in unconventional ways could help improve compliance in patients with hypertension, according to a study in The Journal of Clinical Hypertension.

Celecoxib/amlodipine besylate: Completed Phase III enrollment

Brain receptors targeted to treat inflammatory response and human hypertension

According to current statistics, hypertension affects more than 33% of US adults. Despite the availability of several antihypertensive medications, the morbidity and mortality caused by hypertension is on the rise, suggesting the need for investigati...

Media Advisory: Results of New Research in High Blood Pressure Management Expected Today

MARKHAM, ONTARIO -- (Marketwired) -- 11/09/15 -- Results from the National Heart, Lung and Blood Institute (NHLBI) Systolic Blood Pressure Intervention Trial (SPRINT) will be presented at the American Heart Association's annual scientific meeting in Orlando, Florida this afternoon. SPRINT studied the results of controlling systolic blood pressure to a target of less than 120 millimeters of mercu...

Breakthrough discovery in cause, treatment and prevention of hypertension

Hypertension affects more than four million Australians but the cause of the disease has never been understood. In research published today and presented at an international scientific meeting this week in Vienna, Monash researchers reveal the cause ...

A General Cardiologist's Approach to Managing Hypertension

Dr Henry Black interviews Dr John Bisognano and discusses his approach to managing hypertension and treating resistant hypertension. Medscape Cardiology

Novel Therapeutics in Hypertension and Kidney Disease

Focus on two broad, important concepts emerging in the pharmacology and therapeutics of hypertension and kidney disease. Current Opinion in Nephrology and Hypertension

Veterinary medicine European public assessment report (EPAR): Lodipressin, amlodipine, Revision: 0, Refused

Scientists identify potential therapeutic target for pulmonary hypertension

Cardiovascular diseases are the leading cause of death worldwide. As a prime example, pulmonary hypertension is especially lethal, with one-half of patients dying within three years of being diagnosed. Yale researchers have uncovered a novel cell typ...

Novartis launches new hypertension program in Ghana

The Novartis Foundation and its partners have begun screening patients in a Community-based Hypertension Improvement Project (ComHIP) in Ghana in a two-year program designed to evaluate the impact of an innovative healthcare model on hypertension management and control. With the new healthcare model, Novartis and its partners aim to evaluate the impact of innovative healthcare and improve the cont...

New Guidelines Focus on Pulmonary Hypertension in Kids

TUESDAY, Nov. 3, 2015 -- The first guidelines for diagnosis and treatment of pulmonary hypertension in children have been released by the American Heart Association and the American Thoracic Society. Pulmonary hypertension is a sometimes fatal...

Exercise Appears Safe, Helpful for Pulmonary Hypertension

FRIDAY, Sept. 4, 2015 -- Exercise can be beneficial and safe for people with pulmonary hypertension, researchers report. Pulmonary hypertension is a type of high blood pressure that affects the lungs and heart, causing breathing problems, fatigue...

Severe uncontrolled hypertension contraindicated with Betmiga

Severe uncontrolled hypertension is now listed as a contraindication in the summary of product characteristics for Betmiga (mirabegron; Astellas). Blood pressure should be measured before starting treatment and monitored regularly during treatment, especially in patients with hypertension.

Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension

Pharmacists help patients with hypertension

If you have hypertension, it pays to include a pharmacist in a medical care team.

Hypertension: PATHWAY to improving the treatment of drug-resistant hypertension

From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency

Risk of Renal, CV and Mortality Outcomes in Hypertension

Which hidden risks are the most likely to be lurking for patients with hypertension? Kidney International

Pulmonary Hypertension Market Growth Steady at 2.92% CAGR to 2019 With Increased Focus on Combination Therapies

PUNE, India, October 9, 2015 /PRNewswire/ -- According to the Pulmonary Hypertension - Global Market Research 2015-2019 report, hypertension treatment is shifting toward the use of combination therapies that employ two or more drugs and it may result in better outcomes for the industry. Complete report on pulmonary hypertension market spread across 65 pages, analyzing 4 major companies and suppo...

Hypertension: RGS5 as a mediator of gestational hypertension

Hypertension: Haematopoietic COX-2 in salt-sensitive hypertension

Breakthrough Discovery in Cause, Treatment, and Prevention of Hypertension

Hypertension affects more than four million Australians but the cause of the disease has never been understood. In research published today and presented at an international scientific meeting this week in Vienna, Monash researchers reveal the cause of hypertension and how the disease could be reversed.

Two new studies on the connection between hypertension and cognitive decline

(Oxford University Press USA) With the number of individuals affected by cognitive decline expected to rise over the next few decades, investigating its potential causes is of major public health interest. Two new studies published today in the Ameri...


News Quicklinks